Company / Total Assets
STANDARD BIOTOOLS INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$567.8M
FY2025
5-year range
$275.2M / $612.3M
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $265M in FY2019 to $612M in FY2024.
Based on SEC 10-K filings.
$568M in FY2025 with a 5-year CAGR of +11.8%.
Improved from $323M to $568M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +11.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.8%, indicating consistent growth.
- In FY2025, total assets decreased 7.3% year-over-year.
- Peak total assets was recorded in FY2024.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $567.8M | -7.3% |
| FY2024 | $612.3M | +89.5% |
| FY2023 | $323.1M | -17.2% |
| FY2022 | $390.3M | +41.8% |
| FY2021 | $275.2M | -15.3% |
| FY2020 | $324.8M | +22.6% |
| FY2019 | $264.8M | -8.0% |
| FY2018 | $287.7M | +0.1% |
| FY2017 | $287.4M | -6.2% |
| FY2016 | $306.4M | -17.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026